What development phase is Atgard in?

Atgard is FDA-approved (marketed).

What is the generic name of Atgard?

DICHLORVOS is the generic (nonproprietary) name of Atgard.

Last reviewed 2026-04-20 · How we verify

Atgard (DICHLORVOS)

FDA-approved active Small molecule Quality 15/100

Dichlorvos, also known as Atgard, is a small molecule that targets acetylcholinesterase. It is used to treat certain types of insect infestations. However, there is limited information available on its commercial status, approved indications, and pharmacokinetic properties. Further research is needed to determine its full potential and safety profile. As a result, it is not widely used in human medicine.

At a glance

Generic name	DICHLORVOS
Target	Acetylcholinesterase, Acetylcholinesterase, AChE, EC 3.1.1.7
Modality	Small molecule
Therapeutic area	Neuroscience
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Atgard CI brief — competitive landscape report
Atgard updates RSS · CI watch RSS